Результаты поиска - Elizabeth Fox

Отмена результатов
  1. 1
    Maternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential Therapeutics

    Maternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential Therapeutics по Elizabeth Fox-Edmiston, Judy Van de Water

    Опубликовано 2015
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Clinical Trial Design for Target-Based Therapy

    Clinical Trial Design for Target-Based Therapy по Elizabeth Fox, Gregory A. Curt, Frank M. Balis

    Опубликовано 2002
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Maternal and fetal antibrain antibodies in development and disease

    Maternal and fetal antibrain antibodies in development and disease по Elizabeth Fox, David G. Amaral, Judy Van de Water

    Опубликовано 2012
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  4. 4
    Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors

    Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors по Robin E. Norris, Peter C. Adamson, Vu Thuong Nguyen, Elizabeth Fox

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates

    Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates по Shana Jacobs, Cynthia Lester McCully, Robert F. Murphy, John Bacher, Frank M. Balis, Elizabeth Fox

    Опубликовано 2009
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group

    Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group по AeRang Kim, Brigitte C. Widemann, Mark Krailo, Nalini Jayaprakash, Elizabeth Fox, Brenda J. Weigel, Susan M. Blaney

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors

    Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents... по Elizabeth Fox, Brigitte C. Widemann, Devang Pastakia, Clara C. Chen, Sherry Yang, Diane E. Cole, Frank M. Balis

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas

    Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas по A. Kim, Andrea Gillespie, Eva Dombi, Anne Goodwin, Wendy Goodspeed, Elizabeth Fox, Frank M. Balis, Brigitte C. Widemann

    Опубликовано 2009
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma

    The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma по Frank M. Balis, Christine M. Busch, Ami V. Desai, Emily Hibbitts, Arlene Naranjo, Rochelle Bagatell, Meredith S. Irwin, Elizabeth Fox

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials

    Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group earl... по Wendy B. London, Rochelle Bagatell, Brenda J. Weigel, Elizabeth Fox, Dongjing Guo, Collin Van Ryn, Arlene Naranjo, Julie R. Park

    Опубликовано 2017
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  11. 11
    New Agents, Emerging Late Effects, and the Development of Precision Survivorship

    New Agents, Emerging Late Effects, and the Development of Precision Survivorship по Eric J. Chow, Zoltan Antal, Louis S. Constine, Rebecca Gardner, William H. Wallace, Brent R. Weil, Jennifer M. Yeh, Elizabeth Fox

    Опубликовано 2018
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  12. 12
    Prenatal Exposure to Autism-Specific Maternal Autoantibodies Alters Proliferation of Cortical Neural Precursor Cells, Enlarges Brain, and Increases Neuronal Size in Adult Animals

    Prenatal Exposure to Autism-Specific Maternal Autoantibodies Alters Proliferation of Cortical Neural Precursor Cells, Enlarges Brain, and Increases Neuronal Size in Adult Animals по Verónica Martínez-Cerdeño, Jasmin Camacho, Elizabeth Fox, Elaine N. Miller, Jeanelle Ariza, Devon Kienzle, Kaela Plank, Stephen C. Noctor, Judy Van de Water

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient

    Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient по Aikaterini A. Nella, Maya Lodish, Elizabeth Fox, Frank M. Balis, Martha Quezado, Patricia Whitcomb, Joanne Derdak, Electron Kebebew, Brigitte C. Widemann, Constantine A. Stratakis

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600–Mutant Low-Grade Glioma

    Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600–Mutant Low-Grade Glioma по Éric Bouffet, Birgit Geoerger, Christopher L. Moertel, James A. Whitlock, Isabelle Aerts, Darren Hargrave, Lisa Osterloh, Eugene Tan, Jeea Choi, Mark W. Russo, Elizabeth Fox

    Опубликовано 2022
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003

    Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Al... по Elizabeth Fox, Shreyaskumar Patel, J. Kyle Wathen, Scott M. Schuetze, Sant P. Chawla, David C. Harmon, Denise K. Reinke, Rashmi Chugh, Robert S. Benjamin, Lee J. Helman

    Опубликовано 2012
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study

    Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncol... по Rochelle Bagatell, Robin E. Norris, Ashish M. Ingle, Charlotte H. Ahern, Stephan D. Voss, Elizabeth Fox, Anthony Little, Brenda J. Weigel, Peter C. Adamson, Susan M. Blaney

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Consortium Study

    Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Con... по Yaël P. Mossé, Emily Lipsitz, Elizabeth Fox, David T. Teachey, John M. Maris, Brenda J. Weigel, Peter C. Adamson, Mark A. Ingle, Charlotte H. Ahern, Susan M. Blaney

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315)

    A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot... по James I. Geller, Elizabeth Fox, Brian Turpin, Stuart L. Goldstein, Xiaowei Liu, Charles G. Minard, Rachel A. Kudgus, Joel M. Reid, Stacey L. Berg, Brenda J. Weigel

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412

    A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412 по Kara L. Davis, Elizabeth Fox, Emasenyie Isikwei, Joel M. Reid, Xiaowei Liu, Charles G. Minard, Stephan D. Voss, Stacey L. Berg, Brenda J. Weigel, Crystal L. Mackall

    Опубликовано 2022
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report

    Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report по Jack Su, Lindsay Kilburn, David B. Mansur, Mark Krailo, Allen Buxton, Adesina Adekunle, Amar Gajjar, Peter C. Adamson, Brenda J. Weigel, Elizabeth Fox, Susan M. Blaney, Maryam Fouladi

    Опубликовано 2021
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: